Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
100,991,756
-
Share change
-
+1,003,501
-
Total reported value
-
$815,022,643
-
Put/Call ratio
-
60%
-
Price per share
-
$8.07
-
Number of holders
-
115
-
Value change
-
+$8,360,187
-
Number of buys
-
48
-
Number of sells
-
50
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2018
As of 31 Dec 2018,
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,991,756 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, LLC, BlackRock Inc., GREAT POINT PARTNERS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Vanguard Group Inc, JENNISON ASSOCIATES LLC, VHCP Management II, LLC, and VHCP Management III, LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.